Supervivencia a 5 años por estadio clínico de pacientes con cáncer invasivo de estómago diagnosticados en el Instituto del Cáncer SOLCA Loja durante julio 2009 a diciembre 2010

Abstract

Abstract: To determine the 5-year survival for clinical stage of patients with invasive stomach's cancer by review of medical histories. The study is descriptive, retrospective. Forty five medical histories of patients treated at SOLCA Loja diagnosed with invasive cancer of the stomach in July 2009 to December 2010. The median age at diagnosis was 68 years. 60% were male. According to the histopathologic diagnosis, 53.3% were diffuse gastric adenocarcinoma. 55.56% of patients were diagnosed in clinical stage IV, 31.11% in stage III, stage II 6.67%, and 6.67% in stage I. The survival at 5 years was 100% in patients with stage 1, 33% stage II, 50% stage III, and 0% at 5 years stage IV. Gastric cancer is usually diagnosed in late stages and therefore, the survival rate at 5 years is low. Thus the 5-year survival is inversely proportional to the clinical stage when.